Lauren Harmon
banner
laurenmharmon.bsky.social
Lauren Harmon
@laurenmharmon.bsky.social
Bioinformatics, genetics, epigenetics, hematology. PhD student at Van Andel Institute in Tim Triche’s lab. Mom to the cutest baby boy.
Reposted by Lauren Harmon
🔬Read "bamSliceR: a Bioconductor package for rapid, cross-cohort variant and allelic bias analysis" in Bioinformatics Advances!

Access the full paper here: https://doi.org/10.1093/bioadv/vbaf098

Authors include: @laurenmharmon.bsky.social
May 1, 2025 at 9:31 AM
Reposted by Lauren Harmon
Communications shutdown. Travel ban. Canceled study sections. Now a hiring freeze?

Shutting down the NIH indefinitely without stated cause is literally an act of sabotage.

Left: yesterday. Right: today.
January 22, 2025 at 11:31 PM
Reposted by Lauren Harmon
Kick off the new year with cutting-edge science. Join the NIC, Prof. Christoph Klein and @abattacks.bsky.social for their webinar on "Organoids" happening on Wednesday, 8 January 2025! www.iseh.org/ISEHWebinars
December 13, 2024 at 5:02 PM
Reposted by Lauren Harmon
Hey so #hemesky if you missed @laurenmharmon.bsky.social’s presentation at the germline 🩸🧬 workshop, all is not lost. Come to her poster (which won an ASH Abstract Achievement award) on Monday. ash.confex.com/ash/2024/web...
December 7, 2024 at 12:14 AM
Reposted by Lauren Harmon
Congratulations to @laurenmharmon.bsky.social, a Ph.D. candidate in the @timtriche.bsky.social lab, who recently earned a prestigious F99/K00 award! This fellowship will aid her research in pediatric acute myeloid leukemia. Read our 2023 profile of Lauren here ⬇️
Meet the graduate student: Lauren Harmon – Van Andel Institute
Read about Meet the graduate student: Lauren Harmon on Van Andel Institute – Stay updated on the latest research and groundbreaking discoveries in science and health.
www.vai.org
September 18, 2024 at 3:49 PM
Reposted by Lauren Harmon
Hey there #bloodsky 🩸🧬! Our MLLT10 paper went up in Blood Advances on Friday. Thanks to Oussama Abla at Sick Kids & @laurenmharmon.bsky.social at VAI, it’s finally out. MLLT10 is the weirdest MLL fusion partner. Here we show why, and (maybe) whar to do about it. ashpublications.org/bloodadvance...
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute ...
Key Points. Pediatric MLLT10+ AML have poor prognosis and may benefit from targeted therapiesPICALM::MLLT10+ and X::MLLT10+ patients are hypermethylated similar
ashpublications.org
February 4, 2024 at 2:40 PM